It has been reported that metformin may inhibit PCa growth via repressing mammalian target of rapamycin14 and androgen receptor signaling pathways.15 However, much remains to be understood about metformin’s anticancer properties and the direct molecular mechanism by which metformin inhibits PCa cell migration remains unclear. This evidence concerns the gene AR and posterior cortical atrophy.